U.S. markets closed

Singular Genomics Systems, Inc. (OMIC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.1000-0.0300 (-0.96%)
At close: 04:00PM EDT
3.1000 0.00 (0.00%)
After hours: 04:00PM EDT

Singular Genomics Systems, Inc.

10931 North Torrey Pines Road
Suite 100
La Jolla, CA 92037
United States
858 333 7830

IndustryMedical Instruments & Supplies
Full Time Employees238

Key Executives

NameTitlePayExercisedYear Born
Mr. Andrew SpaventaFounder, CEO & Chairperson of the Board677.71kN/A1985
Mr. David J. DalyPres & COO562.13kN/A1962
Dr. David L. Barker Ph.D.Founder, Member of Scientific Advisory Board & Independent Director32.82kN/A1942
Ms. Daralyn DurieGen. Counsel449.73kN/A1968
Dr. Eli N. Glezer Ph.D.Founder, Chief Scientific Officer & Chair of Scientific Advisory BoardN/AN/A1969
Mr. Dalen MeeterSVP of Fin. & Head of Fin.N/AN/A1978
Mr. Jorge Velarde Jr., MBASr. VP of Corp. Devel. & StrategyN/AN/A1967
Mr. Vincent BrancaccioSr. VP of HRN/AN/A1983
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California.

Corporate Governance

Singular Genomics Systems, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.